In clinical trials, Jeuveau® was shown to temporarily improve the appearance of moderate to severe frown lines. In US studies, 68% and 70% of Jeuveau® patients had a 2-grade or better physician and patient-rated improvement in frown lines at Day 30. But that's not all. In a study conducted in Europe and Canada, 54% of patients had visible results as early as 2 days after treatment.* And at 5 months after treatment, 38% of patients had visible results with Jeuveau®.

Jeuveau® is new to our practice and is a modern-made neurotoxin dedicated exclusively to aesthetics.

If it's your first time getting a treatment, you may be a little nervous. And that's okay! The most common side effects of Jeuveau® include: headache, eyelid dropping, upper respiratory infection, and increased white blood cell count. These are not all the possible side effects of Jeuveau®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1 800-FDA-1088. No serious drug-related adverse events were observed in the studies.

A company called Evolus is behind Jeuveau®. They came on the market in 2019 and have a strong social media presence. You can follow their Instagram @evolus. Jeuveau® is a prescription medicine that is injected into muscles and used in adults for a short period of time (temporary) to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).